Biotech stocks can be potent choices for investors, but it’s important to be a good judge of their potential.
Tag:
Pfizer
-
-
There are opportunities for biotech investors to profit at each stage of clinical trials.
-
Pfizer’s struggles with free cash flow and dividend cuts may have a silver lining if its growth meets expectations.